SCHEMBL6090931

SCHEMBL6090931

CCOC(=O)c1c(-c2ccccc2)c2cc(Cl)ccc2n1CCCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.58
MAPK8 P45983 4/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP1A2 P05177 1/20 0.49
HPGD P15428 1/20 0.49
XBP1 P17861 1/20 0.49
CYP2C19 P33261 1/20 0.49
CSF1R P07333 1/20 0.47
MDM2 Q00987 2/20 0.47
PLA2G2A P14555 2/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
TP53 P04637 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
KDR P35968 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11729659 0.87 KMT2A (0.56) KMT2AMAPK8ALDH1A1CYP1A2HPGD
SCHEMBL5739485 0.86 ACLY (0.53) KMT2AMAPK8MAPTLMNATP53
SCHEMBL6090219 0.83 KMT2A (0.54) KMT2AMAPK8ALDH1A1CYP1A2HPGD
SCHEMBL5746891 0.82 KMT2A (0.52) KMT2AMAPK8ALDH1A1HPGDPLA2G2A
SCHEMBL11730958 0.82 ALDH1A1 (0.51) KMT2AMAPK8ALDH1A1CYP1A2HPGD
SCHEMBL1504118 0.78 MAPT (0.55) KMT2AALDH1A1HPGDMDM2MAPT
SCHEMBL4886339 0.77 PLA2G2A (0.55) KMT2AMAPK8MDM2PLA2G2AMAPT
SCHEMBL22005111 0.76 MAPK8 (0.56) KMT2AMAPK8ALDH1A1PLA2G2AMAPT
SCHEMBL11263827 0.76 KMT2A (0.60) KMT2APLA2G2ASMN1; SMN2
SCHEMBL5172795 0.75 KMT2A (0.50) KMT2AMAPK8HPGDMDM2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 KMT2A 3542/4885MAPK8 3463/4885ALDH1A1 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.